Docoh
Loading...

TEVA Teva- Pharmaceutical Industries

News

From Benzinga Pro
Teva Pharma Highlights Launch Of Authorized Generic Epiduo Forte Gel In US
1 Dec 21
Biotech, News, FDA, General
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the launch of an authorized generic of Epiduo®1 Forte Gel (adapalene and benzoyl peroxide gel
This Day In Market History: UN Partitions Palestine For Independent Jewish State
29 Nov 21
Education, Markets, General
Each day, Benzinga takes a look back at a notable market-related moment that occurred on this date. What Happened: On Nov. 29, 1947, the United Nations voted to partition Palestine to establish a Jewish state.
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
3 Nov 21
Biotech, Earnings, News, Penny Stocks, Guidance, Offerings, Small Cap
Here's a roundup of top developments in the biotech space over the last 24 hours.
71 Biggest Movers From Yesterday
3 Nov 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Avis Budget Group, Inc. (NASDAQ: CAR) shares climbed 108.3% to close at $357.17 on Tuesday after the company reported better-than-expected Q3 adjusted EPS and sales results and added $1 billion to its buyback.
Watching Teva Pharmaceuticals; Traders Circulate Seeking Alpha Blog Post From Contributor 'TEVA Stock: California Ruling De-Risks Story; Upside To $25'
2 Nov 21
News, Trading Ideas
https://seekingalpha.com/article/4464478-teva-california-ruling-de-risks-story
51 Stocks Moving In Tuesday's Mid-Day Session
2 Nov 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Avis Budget Group, Inc. (NASDAQ: CAR) surged 83.9% to $315.37 after the company reported better-than-expected Q3 adjusted EPS and sales results and added $1 billion to its buyback.
California Judge Rules For Drugmakers In Major Opioid Litigation
2 Nov 21
Biotech, Government, Long Ideas, News, Penny Stocks, Health Care, Small Cap, Legal, Movers, Trading Ideas, General
A California judge cleared four drugmakers of liability, accusing the companies of causing widespread opioid addiction in the state. Teva Pharmaceuticals Industries Ltd (NYSE: TEVA),
24 Stocks Moving in Tuesday's Pre-Market Session
2 Nov 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Baosheng Media Group Holdings Limited (NASDAQ: BAOS) rose 119% to $3.43 in pre-market trading after declining 3% on Monday. The company, last month, swung to a loss in the first half of the year.
Teva Reports Encouraging Data From Late-Stage Schizophrenia Trial
1 Nov 21
Biotech, News, Health Care, Movers, Trading Ideas, General
Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2021
28 Oct 21
Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings
Raymond James Downgrades Teva Pharmaceutical Indus to Market Perform
28 Oct 21
News, Downgrades, Analyst Ratings
Raymond James analyst Elliot Wilbur downgrades Teva Pharmaceutical Indus (NYSE:TEVA) from Outperform to Market Perform.
Looking Into Teva Pharmaceutical Indus's Return On Capital Employed
27 Oct 21
Earnings
Pulled from Benzinga Pro data, Teva Pharmaceutical Indus (NYSE:TEVA) posted Q3 earnings of $623.00 million, an increase from Q2 of 7.04%. Sales dropped to $3.89 billion, a 0.59% decrease between quarters.
Teva Q3 Earnings Fall Short Of Expectations; Reaffirms FY21 Guidance
27 Oct 21
Biotech, Earnings, News, Guidance, Health Care, Financing, General
Teva Pharmaceutical Industries Ltd's (NYSE: TEVA) Q3 sales
Teva Pharmaceutical Indus Q3 Adj. EPS $0.59 Misses $0.65 Estimate, Sales $3.89B Miss $4.03B Estimate; Reaffirms Guidance
27 Oct 21
Earnings, News, Guidance
Teva Pharmaceutical Indus (NYSE:TEVA) reported quarterly earnings of $0.59 per share which missed the analyst consensus estimate of $0.65 by 9.23 percent. This is a 1.72 percent increase over earnings of $0.58 per share
Earnings Scheduled For October 27, 2021
27 Oct 21
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • McDonald's (NYSE:MCD) is expected to report quarterly earnings at $2.46 per share on revenue of $6.03 billion.
Teva Pharmaceutical Industries European Affiliate Teva Pharmaceuticals Europe BV Announced New Safety Data On Treatment With COPAXONE Of Breastfeeding Mothers Who Live With Relapsing Multiple Sclerosis
13 Oct 21
News, Global
Teva Pharmaceuticals Europe BV, a European affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and St. Josef Hospital – Katholisches Klinikum Bochum (Bochum, Germany), presented today at ECTRIMS
10 Health Care Stocks With Unusual Options Alerts In Today's Session
8 Oct 21
News, Options, Intraday Update, Markets
This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Unusual trading activity could push option prices to hyperbolic or underperforming levels.
Bitcoin Is The Ferrari And Gold Is The Horse And Buggy, According To Bill Miller
6 Oct 21
Cryptocurrency, News, Small Cap, Top Stories, Markets, Media
Legendary value investor Bill Miller remains bullish on Bitcoin (CRYPTO: BTC) and continues to add to his position.
Teva Stops Production At US Plant After FDA Concerns: Report
4 Oct 21
Biotech, News, Health Care, FDA, General
Teva Reaches Agreement With Louisiana To Settle State's Opioid-Related Claims
28 Sep 21
News
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), has reached an agreement with the Attorney General (AG) of Louisiana that settles the state's opioid-related

Press releases

From Benzinga Pro
Teva Announces Early Tender Results of its Debt Tender Offer, Increase of the Maximum Tender Amount and Election of Early Settlement
10 Nov 21
Press Releases
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) ("Teva") announced today the early tender results in connection with its previously announced tender offers (the "Offers") and that it is increasing the combined
The $11 Trillion Healthcare Industry Is About To Change Forever
4 Nov 21
Small Cap, Opinion, Press Releases
LONDON, Nov. 4, 2021 /PRNewswire/ -- The $11-trillion healthcare industry is going fully digital, disrupting industry giants & government monopolies, and finally giving the power back to the people. That means no
Teva Becomes First Pharmaceutical Company to Execute Sustainability-linked Bond Tied to both Climate and Access to Medicine Targets
3 Nov 21
Press Releases
$5 billion bond is the largest of its kind from any sector and the first issued by a generic medicines company The bond is tied to targets that include improving access to medicines in low- and middle-income
Teva Announces Successful Upsize of Sustainability-Linked Senior Notes Offering and Pricing of $5,000,000,000 of Sustainability-Linked Senior Notes
2 Nov 21
Press Releases
Proceeds to Repay Existing Debt Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) ("Teva") announced today that it successfully upsized and priced approximately $5,000,000,000 (equivalent) of its debut
Thinking about buying stock in Sab Biotherapeutics, Artelo Biosciences, Under Armour, Endo International, or Teva Pharmaceutical?
2 Nov 21
Opinion, Press Releases
NEW YORK, Nov. 2, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SABS, ARTL, UAA, ENDP, and TEVA.
California Judge Rules That Teva Did Not Cause a Public Nuisance or Make False or Misleading Statements About Opioids
1 Nov 21
Press Releases
Today, Orange County, California, Superior Court Judge Peter Wilson issued a decision finding that Teva did not cause a public nuisance in Orange County, Los Angeles County, Santa Clara County and the City of Oakland
New Phase 3 Data Presented at Psych Congress 2021 Showed TV-46000/mdc-IRM Significantly Prolonged Time to Impending Relapse Compared to Placebo in Patients with Schizophrenia
30 Oct 21
Press Releases
Phase 3 RISE study evaluated treatment with TV-46000, a subcutaneous long-acting injectable risperidone formulation New data showed TV-46000 decreased risk of relapse and increased chance of clinical stability versus
Teva Announces Launch of $4,000,000,000 Offering of Sustainability-linked Senior Notes
27 Oct 21
Press Releases
FIRST-EVER GENERIC COMPANY SUSTAINABILITY-LINKED NOTES Company will Increase Access to Medicines in Middle and Low Income Countries Enhanced Commitment to the Environment Teva Pharmaceutical Industries Ltd. (NYSE and
Teva Announces $3,500,000,000 Debt Tender Offers for Notes Due 2022-2024
27 Oct 21
Press Releases
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) ("Teva") announced today that it has commenced tender offers (the "Offers") to purchase for cash for a combined aggregate purchase price (exclusive of accrued
Teva and MODAG Announce Licensing Collaboration for Neurodegenerative Disease Drug Candidate
26 Oct 21
Press Releases
Small molecule candidate Anle138b targets disease modification for multiple system atrophy and other neurological disorders Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and MODAG GmbH today announced a
Teva to Present New Data from Growing Mental Health Portfolio at Psych Congress 2021
21 Oct 21
Press Releases
New Phase 3 RISE study data, post hoc analyses and open-label extension studies to be presented underscore company's heritage in and commitment to mental health and neuroscience Teva Pharmaceuticals, a U.S. affiliate
Teva to Host Conference Call to Discuss Third Quarter 2021 Financial Results at 8 a.m. ET on October 27, 2021
1 Oct 21
Press Releases
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its financial results for the third quarter of 2021 on Wednesday, October 27, 2021 at 7:00 a.m. ET.
Teva to Present 8 Abstracts on AJOVY® (fremanezumab-vfrm) Injection and Hold Symposium on Healthcare Disparities at WCN
30 Sep 21
Press Releases
Extension analyses observed patients taking AJOVY experienced a reduction in migraine and headache days and evaluated disability and health-related quality of life Online symposium to highlight healthcare and neurology
Teva Enlists Sarah Michelle Gellar to Launch "Inhaler Tales" Campaign to Raise Awareness About Inhaler Use in Asthma and COPD
30 Sep 21
Press Releases
Survey of Over 1,000 Asthma and COPD Patients Conducted in Partnership with AAFA Finds Symptoms are Disruptive to Daily Lives for Majority of Respondents Despite Treatment Teva Pharmaceuticals, a U.S. affiliate of Teva
Teva Reaches Agreement with Louisiana to Settle the State's Opioid-Related Claims
28 Sep 21
Press Releases
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), has reached an agreement with the Attorney General (AG) of Louisiana that settles the state's opioid-related claims.